Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Mar;88(3):262-6.
doi: 10.1111/j.1349-7006.1997.tb00376.x.

Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas

H Ojima  1 , T Fukuda, T Nakajima, Y Nagamachi
Affiliations

Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas

H Ojima et al. Jpn J Cancer Res. 1997 Mar.

Abstract

Epstein-Barr virus (EBV) infection was studied in a total of 412 patients with poorly differentiated gastric adenocarcinoma by in situ hybridization for EBV-encoded small RNA. EBV-specific RNA was detected in tumor cell nuclei of 83 (20.1%) of 412 gastric carcinomas, of which 60 were histologically subclassified as gastric carcinoma with lymphoid stroma (GCLS). All EBV-positive gastric carcinomas as well as 90 randomly selected EBV-negative gastric carcinomas were further studied for p53 protein expression by immunohistochemistry. The overexpression of p53 protein was demonstrated in only 7 (8.4%) of 83 EBV-positive gastric carcinomas. This was in marked contrast to the frequency of 34.4% in EBV-negative gastric carcinomas. In addition, a few p53-positive nuclei were characteristically scattered in the tumors of many EBV-positive GCLS, but this was not regarded as p53 overexpression arising from mutation of the gene. Our findings suggested that EBV-associated gastric carcinomas may arise through a different mechanism from other types of gastric carcinomas without EBV infection.

PubMed Disclaimer

References

    1. ) Young , L. S. and Rows , M.Epstein‐Barr virus, lymphomas and Hodgkin's disease . Semin. Cancer Biol , 3 , 273 – 284 ( 1992. ). - PubMed
    1. ) Ambinder , R. F. and Mann , R. B.Detection and characterization of Epstein‐Barr virus in clinical specimens . Am. J, Pathol 145 , 239 – 252 ( 1994. ). - PMC - PubMed
    1. ) Carbone , A. , Dolcetti , R. , Gloghini , A. , Maestro , R. , Vaccher , E. , Di Luca , D. , Tirelli , U. and Biocchi , M.Immunophenotypic and molecular analysis of acquired immune deficiency syndrome‐related and Epstein‐Barr virus‐associated lymphomas: a comparative study . Hum. Pathol , 27 , 133 – 146 ( 1996. ). - PubMed
    1. ) Fukayama , M. , Ibuka , T. , Hayashi , Y. , Ooba , T. , Koike , M. and Mizutani , S.Epstein‐Barr virus in pyothoraxassociated pleural lymphoma . Am. J. Pathol 143 , 1044 – 1049 ( 1993. ). - PMC - PubMed
    1. ) Sasajima , Y. , Yamabe , H. , Kobashi , Y. , Hirai , K. and Mori , S.High expression of the Epstein‐Barr virus latent protein EB nuclear antigen‐2 on pyothorax‐associated lymphomas . Am. J. Pathol 143 , 1280 – 1285 ( 1993. ). - PMC - PubMed

MeSH terms

Substances